Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
Antioxidants · 18.12.2024 · 13 (12) · 1558
DOI: 10.3390/antiox13121558 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 18.12.2024. Verfasst von Xiang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Fundamental Research Funds for the Central University, Nankai University.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly, significantly diminishing quality of life. Currently, there is no available treatment to reverse retinal degeneration and neuronal loss, prompting a focus on interventions that slow the progression of intermediate AMD and geographic atrophy. Berries are rich in bioactive compounds, including flavonoids, anthocyanins, carotenoids, and resveratrol, known for their antioxidant, anti-inflammatory, and anti-angiogenic properties. Preclinical studies suggest that extracts from various berries, such as aronia, honeysuckle, black currant, goji, and bilberry, can improve retinal health by reducing oxidative stress and inflammation. Although clinical trials are limited, emerging evidence indicates that dietary intake of these compounds may enhance visual function and slow the progression of AMD. This review summarizes findings from both animal studies and clinical trials to identify specific berries that have been validated to prevent or delay AMD progression, as well as those with potential therapeutic value. Furthermore, we examine the key phytochemicals present in these berries, their mechanisms of action on macular degeneration, and their distinct properties for therapeutic application. A deeper understanding of these characteristics could enable the rational appliance of berries, especially wolfberry, and berry-derived components, such as carotenoids and anthocyanins, to optimize better therapeutic outcomes in AMD management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, China.
ORCID-Profile: Xiang Li
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central University, Nankai University
Zitieren
APA
Li, X., Zhao, L., Zhang, B., & Wang, S. (2024). Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration. Antioxidants, 13(12), 1558. https://doi.org/10.3390/antiox13121558
Vancouver
Li X, Zhao L, Zhang B, Wang S. Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration. Antioxidants. 2024;13(12):1558. doi:10.3390/antiox13121558
BibTeX
@article{Li2024,
author = {Li, Xiang and Zhao, Lingda and Zhang, Bowei and Wang, Shuo},
title = {Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {12},
pages = {1558},
doi = {10.3390/antiox13121558}
}
EUVIMED